KP
Kalpit Patel B. Riley Securities Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Journey Medical
DERM
$184M
| $7.01 | $12 |
71%
upside
| Buy |
30 Jul ‘25
1 month ago |
|
2
Kymera Therapeutics
KYMR
$3.11B
| $43.51 | $60 |
38%
upside
| Buy |
3 Jun ‘25
3 months ago |
|
|
BCYC
3
Bicycle Therapeutics
BCYC
$496M
| $7.16 | $14 |
96%
upside
| Neutral |
2 May ‘25
4 months ago |
|
4
ArriVent BioPharma
AVBP
$819M
| $20.19 | $37 |
83%
upside
| Buy |
20 Mar ‘25
5 months ago |
|
5
Rigel Pharmaceuticals
RIGL
$742M
| $41.34 | $24 |
42%
downside
| Neutral |
5 Mar ‘25
6 months ago |
|
6
Geron
GERN
$893M
| $1.40 | $3.50 |
150%
upside
| Buy |
18 Feb ‘25
6 months ago |
|
7
Verastem
VSTM
$663M
| $10.77 | $9 |
16%
downside
| Buy |
31 Jan ‘25
7 months ago |
|
8
Foghorn Therapeutics
FHTX
$326M
| $5.77 | $10 |
73%
upside
| Buy |
30 Jan ‘25
7 months ago |
|
9
PDS Biotechnology
PDSB
$56.4M
| $1.20 | $7 |
483%
upside
| Buy |
25 Nov ‘24
9 months ago |
|
10
Corbus Pharmaceuticals
CRBP
$121M
| $9.86 | $40 |
306%
upside
| Buy |
20 Sep ‘24
11 months ago |
|
11
Ovid Therapeutics
OVID
$87.5M
| $1.23 | $3 |
144%
upside
| Buy |
18 Jun ‘24
1 year ago |
|
12
Viridian Therapeutics
VRDN
$1.53B
| $18.72 | $20 |
7%
upside
| Neutral |
9 May ‘24
1 year ago |
|
13
X4 Pharmaceuticals
XFOR
$78.6M
| $3.50 | $30 |
757%
upside
| Neutral |
12 Dec ‘23
1 year ago |
|
14
Syndax Pharmaceuticals
SNDX
$1.47B
| $17.04 | $36 |
111%
upside
| Buy |
25 Jul ‘23
2 years ago |
|
15
IN8bio
INAB
$9.83M
| $2.17 | $90 |
4,047%
upside
| Neutral |
11 Nov ‘22
2 years ago |
|
16
Allogene Therapeutics
ALLO
$255M
| $1.15 | $18 |
1,465%
upside
| Buy |
22 Sep ‘22
3 years ago |
|
17
Entera Bio
ENTX
$94.1M
| $2.06 | $5 |
143%
upside
| Buy |
19 Jul ‘22
3 years ago |
|
18
MiNK Therapeutics
INKT
$66.9M
| $14.80 | $100 |
576%
upside
| Buy |
24 Jan ‘22
3 years ago |
|
19
Dianthus Therapeutics
DNTH
$853M
| $26.50 | $96 |
262%
upside
| Buy |
24 Jan ‘22
3 years ago |
|
20
Forte Biosciences
FBRX
$140M
| $11.26 | $75 |
566%
upside
| Neutral |
3 Sep ‘21
4 years ago |
|